🇺🇸 FDA
Patent

US 6995141

Interleukin 1β protease and interleukin 1β protease inhibitors

expired A61KA61K38/00

Quick answer

US patent 6995141 (Interleukin 1β protease and interleukin 1β protease inhibitors) held by Vertex Pharmaceuticals Incorporated expires Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 07 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K38/00